$AMN
AMN HEALTHCARE SERVICES INC Stock $amn

$amn Overview Financials Valuation SEC Filings Company Website

2015 Q4 Form 10-Q Financial Statement

#000114275015000011 Filed on November 06, 2015

Income Statement

Concept	2015 Q4	2015 Q3	2014 Q3
Revenue	$402.6M	$382.9M	$264.6M
YoY Change	43.95%	44.7%	2.91%
Cost Of Revenue	$270.7M	$256.9M	$184.3M
YoY Change	38.82%	39.38%	1.57%
Gross Profit	$131.8M	$126.0M	$80.31M
YoY Change	55.62%	56.91%	6.13%
Gross Profit Margin	32.74%	32.91%	30.35%
Selling, General & Admin	$90.20M	$83.10M	$60.32M
YoY Change	46.19%	37.76%	8.48%
% of Gross Profit	68.43%	65.95%	75.11%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$5.400M	$5.304M	$4.086M
YoY Change	31.71%	29.81%	23.18%
% of Gross Profit	4.1%	4.21%	5.09%
Operating Expenses	$95.50M	$88.40M	$64.41M
YoY Change	45.36%	37.26%	9.31%
Operating Profit	$36.30M	$37.61M	$15.90M
YoY Change	91.11%	136.51%	-5.04%
Interest Expense	-$2.000M	$2.013M	$1.433M
YoY Change	53.85%	40.47%	-22.12%
% of Operating Profit	-5.51%	5.35%	9.01%
Other Income/Expense, Net	-$2.300M
YoY Change	-2400.0%
Pretax Income	$34.30M	$35.59M	$14.47M
YoY Change	94.89%	146.02%	-2.93%
Income Tax	$14.20M	$1.947M	$5.969M
% Of Pretax Income	41.4%	5.47%	41.26%
Net Earnings	$20.17M	$33.65M	$8.499M
YoY Change	103.79%	295.89%	-1.35%
Net Earnings / Revenue	5.01%	8.79%	3.21%
Basic Earnings Per Share	$0.42	$0.71	$0.18
Diluted Earnings Per Share	$0.41	$0.69	$0.18
COMMON SHARES
Basic Shares Outstanding	47.69M shares	47.67M shares	46.55M shares
Diluted Shares Outstanding		48.98M shares	48.12M shares

Balance Sheet

Concept	2015 Q4	2015 Q3	2014 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$9.600M	$14.40M	$9.700M
YoY Change	-26.72%	48.45%	-69.4%
Cash & Equivalents	$9.576M	$14.41M	$9.663M
Short-Term Investments
Other Short-Term Assets	$23.72M	$25.08M	$53.80M
YoY Change	37.92%	-53.39%	74.68%
Inventory	$3.428B
Prepaid Expenses	$13.53M	$12.82M
Receivables	$278.0M	$248.8M	$164.1M
Other Receivables	$3.700M	$4.200M	$0.00
Total Short-Term Assets	$375.6M	$369.0M	$249.1M
YoY Change	32.89%	48.11%	10.1%
LONG-TERM ASSETS
Property, Plant & Equipment	$50.13M	$45.41M	$29.20M
YoY Change	52.48%	55.49%	67.78%
Goodwill	$204.8M	$201.4M	$144.9M
YoY Change	32.64%	38.99%	17.53%
Intangibles	$175.0M	$177.3M	$144.5M
YoY Change	14.72%	22.73%	9.36%
Long-Term Investments	$5.076B
YoY Change	14.5%
Other Assets	$47.57M	$46.63M	$40.05M
YoY Change	22.89%	16.45%	74.09%
Total Long-Term Assets	$504.8M	$496.3M	$379.7M
YoY Change	26.82%	30.7%	19.44%
TOTAL ASSETS
Total Short-Term Assets	$375.6M	$369.0M	$249.1M
Total Long-Term Assets	$504.8M	$496.3M	$379.7M
Total Assets	$880.4M	$865.2M	$628.8M
YoY Change	29.34%	37.6%	15.55%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$118.8M	$113.2M	$66.95M
YoY Change	50.42%	69.01%	22.08%
Accrued Expenses	$24.50M	$88.50M	$64.60M
YoY Change	-63.97%	37.0%	19.19%
Deferred Revenue
YoY Change
Short-Term Debt	$100.0K	$2.500M	$0.00
YoY Change
Long-Term Debt Due	$37.50M	$7.500M	$7.500M
YoY Change	400.0%	0.0%
Total Short-Term Liabilities	$251.0M	$250.1M	$147.8M
YoY Change	40.79%	69.26%	28.15%
LONG-TERM LIABILITIES
Long-Term Debt	$181.0M	$176.8M	$138.8M
YoY Change	33.38%	27.38%	-6.59%
Other Long-Term Liabilities	$78.13M	$75.41M	$96.88M
YoY Change	0.59%	-22.16%	34.6%
Total Long-Term Liabilities	$78.13M	$75.41M	$96.88M
YoY Change	0.59%	-22.16%	34.6%
TOTAL LIABILITIES
Total Short-Term Liabilities	$251.0M	$250.1M	$147.8M
Total Long-Term Liabilities	$78.13M	$75.41M	$96.88M
Total Liabilities	$532.6M	$541.3M	$383.4M
YoY Change	25.56%	41.18%	14.14%
SHAREHOLDERS EQUITY
Retained Earnings	-$96.17M	-$116.3M	-$188.0M
YoY Change	-45.99%	-38.11%	-14.42%
Common Stock	$477.0K	$477.0K	$466.0K
YoY Change	2.36%	2.36%	1.3%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$0.00
YoY Change
Treasury Stock Shares	0.000 shares
Shareholders Equity	$347.9M	$324.0M	$245.4M
YoY Change
Total Liabilities & Shareholders Equity	$880.4M	$865.2M	$628.8M
YoY Change	29.34%	37.6%	15.55%

Cashflow Statement

Concept	2015 Q4	2015 Q3	2014 Q3
OPERATING ACTIVITIES
Net Income	$20.17M	$33.65M	$8.499M
YoY Change	103.79%	295.89%	-1.35%
Depreciation, Depletion And Amortization	$5.400M	$5.304M	$4.086M
YoY Change	31.71%	29.81%	23.18%
Cash From Operating Activities	$700.0K	$21.90M	$15.50M
YoY Change	-86.54%	41.29%	-39.92%
INVESTING ACTIVITIES
Capital Expenditures	-$5.900M	-$6.500M	-$4.400M
YoY Change	22.92%	47.73%	300.0%
Acquisitions
YoY Change
Other Investing Activities	-$4.600M	-$4.200M	-$100.0K
YoY Change	-64.89%	4100.0%	-107.69%
Cash From Investing Activities	-$10.50M	-$10.70M	-$4.500M
YoY Change	-41.34%	137.78%	-2350.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	4.900M	-11.30M	-6.800M
YoY Change	-69.37%	66.18%	41.67%
NET CHANGE
Cash From Operating Activities	700.0K	21.90M	15.50M
Cash From Investing Activities	-10.50M	-10.70M	-4.500M
Cash From Financing Activities	4.900M	-11.30M	-6.800M
Net Change In Cash	-4.900M	-100.0K	4.200M
YoY Change	-248.48%	-102.38%	-80.19%
FREE CASH FLOW
Cash From Operating Activities	$700.0K	$21.90M	$15.50M
Capital Expenditures	-$5.900M	-$6.500M	-$4.400M
Free Cash Flow	$6.600M	$28.40M	$19.90M
YoY Change	-34.0%	42.71%	-26.02%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	ahs	Noncash Or Part Noncash Acquisition Earn Out Liability NoncashOrPartNoncashAcquisitionEarnOutLiability	2700000	USD
CY2014Q4	ahs	Accounts Payable And Accrued Expenses Excluding Accrued Compensation And Benefits Current AccountsPayableAndAccruedExpensesExcludingAccruedCompensationAndBenefitsCurrent	78993000	USD
	ahs	Noncash Or Part Noncash Acquisition Holdback Provision NoncashOrPartNoncashAcquisitionHoldbackProvision	0	USD
CY2015Q3	ahs	Accounts Payable And Accrued Expenses Excluding Accrued Compensation And Benefits Current AccountsPayableAndAccruedExpensesExcludingAccruedCompensationAndBenefitsCurrent	113152000	USD
CY2014Q4	ahs	Accounts Payable To Subcontractor AccountsPayableToSubcontractor	33474000	USD
CY2015Q3	ahs	Accounts Payable To Subcontractor AccountsPayableToSubcontractor	53575000	USD
CY2014Q4	ahs	Accountsreceivablesubcontractor Accountsreceivablesubcontractor	28443000	USD
CY2015Q3	ahs	Accountsreceivablesubcontractor Accountsreceivablesubcontractor	49521000	USD
CY2014Q4	ahs	Accrued Travel Expense AccruedTravelExpense	2413000	USD
CY2015Q3	ahs	Accrued Travel Expense AccruedTravelExpense	2868000	USD
	ahs	Increase Decreasein Accounts Receivablessubcontractor IncreaseDecreaseinAccountsReceivablessubcontractor	3298000	USD
	ahs	Increase Decreasein Accounts Receivablessubcontractor IncreaseDecreaseinAccountsReceivablessubcontractor	21078000	USD
	ahs	Noncash Or Part Noncash Acquisition Earn Out Liability NoncashOrPartNoncashAcquisitionEarnOutLiability	0	USD
	ahs	Noncash Or Part Noncash Acquisition Holdback Provision NoncashOrPartNoncashAcquisitionHoldbackProvision	500000	USD
	ahs	Purchaseoffixedassetsrecordedinaccountspayableandaccruedexpenses Purchaseoffixedassetsrecordedinaccountspayableandaccruedexpenses	3751000	USD
	ahs	Purchaseoffixedassetsrecordedinaccountspayableandaccruedexpenses Purchaseoffixedassetsrecordedinaccountspayableandaccruedexpenses	2206000	USD
	ahs	Supplemental Disclosures Of Non Cash Investing And Financing Activities Goodwill SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesGoodwill	0	USD
	ahs	Supplemental Disclosures Of Non Cash Investing And Financing Activities Goodwill SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesGoodwill	46891000	USD
	ahs	Supplemental Disclosures Of Non Cash Investing And Financing Activities Intangible Assets SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesIntangibleAssets	0	USD
	ahs	Supplemental Disclosures Of Non Cash Investing And Financing Activities Intangible Assets SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesIntangibleAssets	33592000	USD
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
	dei	Document Period End Date DocumentPeriodEndDate	2015-09-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001142750
CY2015Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	47693968	shares
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	AMN HEALTHCARE SERVICES INC
CY2014Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	78993000	USD
CY2015Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	113152000	USD
CY2014Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	30039000	USD
CY2015Q3	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	48109000	USD
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	12000	shares
CY2014Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	186274000	USD
CY2015Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	248779000	USD
CY2014Q4	us-gaap	Accrued Bonuses Current And Noncurrent AccruedBonusesCurrentAndNoncurrent	15196000	USD
CY2015Q3	us-gaap	Accrued Bonuses Current And Noncurrent AccruedBonusesCurrentAndNoncurrent	20218000	USD
CY2014Q4	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	1871000	USD
CY2015Q3	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	2517000	USD
CY2014Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	21857000	USD
CY2015Q3	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	32569000	USD
CY2014Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	68814000	USD
CY2015Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	74460000	USD
CY2014Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-356000	USD
CY2015Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-645000	USD
CY2014Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	434529000	USD
CY2015Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	440465000	USD
CY2014Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	4515000	USD
CY2015Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	7460000	USD
CY2014Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	286000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	344000	shares
CY2014Q4	us-gaap	Assets Assets	681916000	USD
CY2015Q3	us-gaap	Assets Assets	865238000	USD
CY2014Q4	us-gaap	Assets Current AssetsCurrent	282670000	USD
CY2015Q3	us-gaap	Assets Current AssetsCurrent	368981000	USD
CY2014Q4	us-gaap	Bank Overdrafts BankOverdrafts	6338000	USD
CY2015Q3	us-gaap	Bank Overdrafts BankOverdrafts	2548000	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-300000	USD
CY2014Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	78593000	USD
CY2015Q3	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	93485000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	15580000	USD
CY2014Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9663000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13073000	USD
CY2015Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14408000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-5917000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	1335000	USD
CY2014Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2015Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2015Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	46639000	shares
CY2015Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	47694000	shares
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	46639000	shares
CY2014Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	3177000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	27330000	USD
CY2015Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	4944000	USD
CY2015Q3	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	18378000	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	32491000	USD
CY2015Q3	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	39000000	USD
CY2015Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	47694000	shares
CY2014Q4	us-gaap	Common Stock Value CommonStockValue	466000	USD
CY2015Q3	us-gaap	Common Stock Value CommonStockValue	477000	USD
CY2014Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	8574000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	23351000	USD
CY2015Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	33334000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	61437000	USD
CY2014Q3	us-gaap	Cost Of Revenue CostOfRevenue	184278000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	524957000	USD
CY2015Q3	us-gaap	Cost Of Revenue CostOfRevenue	256850000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	722954000	USD
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	0	USD
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	1000000	USD
CY2014Q4	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	20729000	USD
CY2015Q3	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	21968000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1768000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	17683000	USD
CY2014Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4086000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	11916000	USD
CY2015Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5304000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	15631000	USD
CY2014Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.18
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.50
CY2015Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.71
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.30
CY2014Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.18
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.49
CY2015Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.69
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.27
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	29000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	42000	USD
CY2014Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	67995000	USD
CY2015Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	88492000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	1780000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	7269000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	1780000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	7269000	USD
	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	0	USD
	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	26340000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	41963000	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	50725000	USD
CY2014Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	17761000	USD
CY2015Q3	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	21158000	USD
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-50000	USD
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-3000	USD
CY2014Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-3113000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2014Q4	us-gaap	Goodwill Goodwill	154387000	USD
CY2015Q3	us-gaap	Goodwill Goodwill	201444000	USD
CY2014Q3	us-gaap	Gross Profit GrossProfit	80306000	USD
	us-gaap	Gross Profit GrossProfit	231421000	USD
CY2015Q3	us-gaap	Gross Profit GrossProfit	126009000	USD
	us-gaap	Gross Profit GrossProfit	337559000	USD
CY2014Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	14468000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	41044000	USD
CY2015Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	35594000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	86754000	USD
CY2014Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5969000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	17722000	USD
CY2015Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1947000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	25028000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	12732000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	20655000	USD
CY2014Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	3503000	USD
CY2015Q3	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	4195000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-4302000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	25808000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	19516000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	46732000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-37000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	1140000	USD
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	8625000	USD
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	16707000	USD
	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-484000	USD
	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-1008000	USD
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	733000	USD
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	6111000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	188000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	3454000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	4662000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-4365000	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	1935000	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	2213000	USD
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	-11141000	USD
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	0	USD
	us-gaap	Increase Decrease In Restricted Cash For Operating Activities IncreaseDecreaseInRestrictedCashForOperatingActivities	9038000	USD
CY2014Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	18000000	USD
CY2015Q3	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	30000000	USD
CY2014Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	0	USD
CY2015Q3	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	45500000	USD
	us-gaap	Increase Decrease In Restricted Cash For Operating Activities IncreaseDecreaseInRestrictedCashForOperatingActivities	5858000	USD
CY2014Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	152517000	USD
CY2015Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	177347000	USD
CY2014Q3	us-gaap	Interest Expense InterestExpense	1433000	USD
	us-gaap	Interest Expense InterestExpense	7908000	USD
CY2015Q3	us-gaap	Interest Expense InterestExpense	2013000	USD
	us-gaap	Interest Expense InterestExpense	5797000	USD
	us-gaap	Interest Paid Capitalized InterestPaidCapitalized	83000	USD
	us-gaap	Interest Paid Capitalized InterestPaidCapitalized	173000	USD
	us-gaap	Interest Paid Net InterestPaidNet	3687000	USD
	us-gaap	Interest Paid Net InterestPaidNet	4334000	USD
CY2014Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	5340000	USD
CY2015Q3	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	5224000	USD
CY2015Q1	us-gaap	Lessee Leasing Arrangements Operating Leases Term Of Contract LesseeLeasingArrangementsOperatingLeasesTermOfContract	P10Y
CY2014Q4	us-gaap	Liabilities Liabilities	425335000	USD
CY2015Q3	us-gaap	Liabilities Liabilities	541273000	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	681916000	USD
CY2015Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	865238000	USD
	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	0	USD
	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	22526000	USD
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	178295000	USD
CY2015Q3	us-gaap	Liabilities Current LiabilitiesCurrent	250114000	USD
CY2014Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	136875000	USD
CY2015Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable	131250000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-18119000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	51290000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-10320000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-105634000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	22493000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	55637000	USD
CY2014Q3	us-gaap	Net Income Loss NetIncomeLoss	8499000	USD
	us-gaap	Net Income Loss NetIncomeLoss	23322000	USD
CY2015Q3	us-gaap	Net Income Loss NetIncomeLoss	33647000	USD
	us-gaap	Net Income Loss NetIncomeLoss	61726000	USD
CY2014Q4	us-gaap	Notes Payable Current NotesPayableCurrent	7500000	USD
CY2015Q3	us-gaap	Notes Payable Current NotesPayableCurrent	7500000	USD
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	segment
CY2014Q3	us-gaap	Operating Expenses OperatingExpenses	64405000	USD
	us-gaap	Operating Expenses OperatingExpenses	182469000	USD
CY2015Q3	us-gaap	Operating Expenses OperatingExpenses	88402000	USD
	us-gaap	Operating Expenses OperatingExpenses	245008000	USD
	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	-331000	USD
CY2014Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	15901000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	48952000	USD
CY2015Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	37607000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	92551000	USD
CY2015Q1	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	23956000	USD
CY2014Q4	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	1762000	USD
CY2015Q3	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	1517000	USD
CY2014Q4	us-gaap	Other Assets Current OtherAssetsCurrent	17200000	USD
CY2015Q3	us-gaap	Other Assets Current OtherAssetsCurrent	25077000	USD
CY2014Q4	us-gaap	Other Assets Miscellaneous Current OtherAssetsMiscellaneousCurrent	4643000	USD
CY2015Q3	us-gaap	Other Assets Miscellaneous Current OtherAssetsMiscellaneousCurrent	7739000	USD
CY2014Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	39895000	USD
CY2015Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	46634000	USD
CY2014Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	75000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	29000	USD
CY2015Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	54000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	42000	USD
CY2014Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	75000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	29000	USD
CY2015Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-313000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-289000	USD
CY2014Q3	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	0	USD
	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	0	USD
CY2015Q3	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	-367000	USD
CY2014Q4	us-gaap	Other Employee Related Liabilities Current OtherEmployeeRelatedLiabilitiesCurrent	99000	USD
CY2015Q3	us-gaap	Other Employee Related Liabilities Current OtherEmployeeRelatedLiabilitiesCurrent	813000	USD
CY2014Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2630000	USD
CY2015Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	6026000	USD
CY2014Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	77674000	USD
CY2015Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	75409000	USD
	us-gaap	Other Noncash Expense OtherNoncashExpense	1104000	USD
	us-gaap	Other Noncash Expense OtherNoncashExpense	1445000	USD
	us-gaap	Payments For Previous Acquisition PaymentsForPreviousAcquisition	0	USD
	us-gaap	Payments For Previous Acquisition PaymentsForPreviousAcquisition	165000	USD
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	3488000	USD
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	4361000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	11513000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	81097000	USD
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	5000000	USD
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	1000000	USD
	us-gaap	Payments To Acquire Life Insurance Policies PaymentsToAcquireLifeInsurancePolicies	2174000	USD
	us-gaap	Payments To Acquire Life Insurance Policies PaymentsToAcquireLifeInsurancePolicies	2250000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	14287000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	21122000	USD
CY2014Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2015Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2014Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2015Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2014Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2015Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2014Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2015Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2014Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2015Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2014Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	10350000	USD
CY2015Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	12818000	USD
	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	150000000	USD
	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	0	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	1792000	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	3663000	USD
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	29500000	USD
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	84500000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	101694000	USD
CY2015Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	119867000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	32880000	USD
CY2015Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	45407000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2915000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	5315000	USD
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	39500000	USD
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	27000000	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	472000	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	4000	USD
	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	153370000	USD
	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	5625000	USD
CY2014Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	9054000	USD
CY2015Q3	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	13143000	USD
CY2014Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	19567000	USD
CY2015Q3	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	25425000	USD
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-178058000	USD
CY2015Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-116332000	USD
CY2014Q3	us-gaap	Revenues Revenues	264584000	USD
	us-gaap	Revenues Revenues	756378000	USD
CY2015Q3	us-gaap	Revenues Revenues	382859000	USD
	us-gaap	Revenues Revenues	1060513000	USD
CY2014Q4	us-gaap	Self Insurance Reserve Current SelfInsuranceReserveCurrent	7380000	USD
CY2015Q3	us-gaap	Self Insurance Reserve Current SelfInsuranceReserveCurrent	7403000	USD
CY2014Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	60319000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	170553000	USD
CY2015Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	83098000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	229377000	USD
CY2014Q3	us-gaap	Share Based Compensation ShareBasedCompensation	1791000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	5361000	USD
CY2015Q3	us-gaap	Share Based Compensation ShareBasedCompensation	2021000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	6551000	USD
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	256581000	USD
CY2015Q3	us-gaap	Stockholders Equity StockholdersEquity	323965000	USD
CY2014Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1576000	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1499000	shares
CY2015Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1304000	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1271000	shares
CY2014Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48122000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	47959000	shares
CY2015Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48978000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48737000	shares
CY2014Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	46546000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	46460000	shares
CY2015Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	47674000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	47466000	shares
CY2014Q4	us-gaap	Workers Compensation Liability Current WorkersCompensationLiabilityCurrent	5830000	USD
CY2015Q3	us-gaap	Workers Compensation Liability Current WorkersCompensationLiabilityCurrent	7539000	USD
	us-gaap	Basis Of Accounting BasisOfAccounting	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">BASIS OF PRESENTATION</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The condensed consolidated balance sheets and related condensed consolidated statements of comprehensive income and cash flows contained in this Quarterly Report on Form 10-Q (this “Quarterly Report”), which are unaudited, include the accounts of AMN Healthcare Services, Inc. and its wholly-owned subsidiaries (collectively, the “Company”). All significant intercompany balances and transactions have been eliminated in consolidation. In the opinion of management, all entries necessary for a fair presentation of such unaudited condensed consolidated financial statements have been included. These entries consisted of all normal recurring items. The results of operations for the interim period are not necessarily indicative of the results to be expected for any other interim period or for the entire fiscal year or for any future period. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The unaudited condensed consolidated financial statements do not include all information and notes necessary for a complete presentation of financial position, results of operations and cash flows in conformity with accounting principles generally accepted in the United States. Please refer to the Company’s audited consolidated financial statements and the related notes for the fiscal year ended December 31, </font><font style="font-family:inherit;font-size:10pt;">2014</font><font style="font-family:inherit;font-size:10pt;">, contained in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, </font><font style="font-family:inherit;font-size:10pt;">2014</font><font style="font-family:inherit;font-size:10pt;">, filed with the Securities and Exchange Commission on February 25, 2015 (“2014 Annual Report”). </font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make a number of estimates and assumptions relating to the reporting of assets and liabilities and the disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenue and expenses during the reporting periods. On an ongoing basis, the Company evaluates its estimates, including those related to asset impairments, accruals for self-insurance, compensation and related benefits, accounts receivable, contingencies and litigation, and income taxes. Actual results could differ from those estimates under different assumptions or conditions. </font></div><div style="line-height:120%;padding-top:12px;text-indent:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Reclassification</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain reclassifications that are not material have been made to the prior year’s consolidated financial statements to conform to the current year presentation.</font></div></div>
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make a number of estimates and assumptions relating to the reporting of assets and liabilities and the disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenue and expenses during the reporting periods. On an ongoing basis, the Company evaluates its estimates, including those related to asset impairments, accruals for self-insurance, compensation and related benefits, accounts receivable, contingencies and litigation, and income taxes. Actual results could differ from those estimates under different assumptions or conditions. </font></div></div>

Files In Submission

Name	View Source	Status
0001142750-15-000011-index-headers.html	Edgar Link	pending
0001142750-15-000011-index.html	Edgar Link	pending
0001142750-15-000011.txt	Edgar Link	pending
0001142750-15-000011-xbrl.zip	Edgar Link	pending
ahs-20150930.xml	Edgar Link	completed
ahs-20150930.xsd	Edgar Link	pending
ahs-20150930x10q.htm	Edgar Link	pending
ahs-20150930_cal.xml	Edgar Link	unprocessable
ahs-20150930_def.xml	Edgar Link	unprocessable
ahs-20150930_lab.xml	Edgar Link	unprocessable
ahs-20150930_pre.xml	Edgar Link	unprocessable
ahs-ex311x20150930x10q.htm	Edgar Link	pending
ahs-ex312x20150930x10q.htm	Edgar Link	pending
ahs-ex321x20150930x10q.htm	Edgar Link	pending
ahs-ex322x20150930x10q.htm	Edgar Link	pending
amnlogoa01a01a01a03.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AMN
AMN HEALTHCARE SERVICES INC Stock $amn

2015 Q4 Form 10-Q Financial Statement

#000114275015000011 Filed on November 06, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AMN AMN HEALTHCARE SERVICES INC Stock $amn

2015 Q4 Form 10-Q Financial Statement

#000114275015000011 Filed on November 06, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AMN
AMN HEALTHCARE SERVICES INC Stock $amn